Addex Therapeutics Ownership 2024 | Who Owns Addex Therapeutics Now?
Institutional Ownership
6.21%
Institutional Holders
5.00
Addex Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
NEA MANAGEMENT COMPANY, LLC | - | - | - | -180,000 | -100.00% | - | Dec 31, 2023 |
BAADER BANK AKTIENGESELLSCHAFT | - | - | - | -19,203 | -100.00% | - | Dec 31, 2023 |
JANE STREET GROUP, LLC | - | - | - | -10,578 | -100.00% | - | Dec 31, 2023 |
ARMISTICE CAPITAL, LLC | - | - | - | -537,000 | -100.00% | - | Dec 31, 2023 |
UBS GROUP AG | - | - | - | -74 | -100.00% | - | Dec 31, 2023 |
Addex Therapeutics's largest institutional shareholder is NEA MANAGEMENT COMPANY, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
NEA MANAGEMENT COMPANY, LLC | - | - | - | -180,000 | -100.00% | - | Dec 31, 2023 |
BAADER BANK AKTIENGESELLSCHAFT | - | - | - | -19,203 | -100.00% | - | Dec 31, 2023 |
JANE STREET GROUP, LLC | - | - | - | -10,578 | -100.00% | - | Dec 31, 2023 |
ARMISTICE CAPITAL, LLC | - | - | - | -537,000 | -100.00% | - | Dec 31, 2023 |
UBS GROUP AG | - | - | - | -74 | -100.00% | - | Dec 31, 2023 |
The largest Addex Therapeutics shareholder by % of total assets is NEA MANAGEMENT COMPANY, LLC. The company owns 0.00 shares of Addex Therapeutics (ADXN), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
UBS GROUP AG | - | - | - | -74 | -100.00% | - | Dec 31, 2023 |
JANE STREET GROUP, LLC | - | - | - | -10,578 | -100.00% | - | Dec 31, 2023 |
BAADER BANK AKTIENGESELLSCHAFT | - | - | - | -19,203 | -100.00% | - | Dec 31, 2023 |
NEA MANAGEMENT COMPANY, LLC | - | - | - | -180,000 | -100.00% | - | Dec 31, 2023 |
ARMISTICE CAPITAL, LLC | - | - | - | -537,000 | -100.00% | - | Dec 31, 2023 |
As of Dec 31 2023, Addex Therapeutics's largest institutional buyer is UBS GROUP AG. The company purchased -74.00 stocks of ADXN, valued at -.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ARMISTICE CAPITAL, LLC | - | - | - | -537,000 | -100.00% | - | Dec 31, 2023 |
NEA MANAGEMENT COMPANY, LLC | - | - | - | -180,000 | -100.00% | - | Dec 31, 2023 |
BAADER BANK AKTIENGESELLSCHAFT | - | - | - | -19,203 | -100.00% | - | Dec 31, 2023 |
JANE STREET GROUP, LLC | - | - | - | -10,578 | -100.00% | - | Dec 31, 2023 |
UBS GROUP AG | - | - | - | -74 | -100.00% | - | Dec 31, 2023 |
As of Dec 31 2023, Addex Therapeutics's biggest institutional seller is ARMISTICE CAPITAL, LLC. The company sold -0.54M shares of ADXN, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ARMISTICE CAPITAL, LLC | - | - | - | -537,000 | -100.00% | - | Dec 31, 2023 |
NEA MANAGEMENT COMPANY, LLC | - | - | - | -180,000 | -100.00% | - | Dec 31, 2023 |
BAADER BANK AKTIENGESELLSCHAFT | - | - | - | -19,203 | -100.00% | - | Dec 31, 2023 |
JANE STREET GROUP, LLC | - | - | - | -10,578 | -100.00% | - | Dec 31, 2023 |
UBS GROUP AG | - | - | - | -74 | -100.00% | - | Dec 31, 2023 |
Addex Therapeutics's largest sold out institutional shareholder by shares sold is ARMISTICE CAPITAL, LLC, sold -0.54M shares, valued at -, as of undefined.
Addex Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Sep, 23 | 5 | 66.67% |
30 Jun, 23 | 3 | -57.14% |
31 Mar, 23 | 7 | - |
31 Dec, 22 | 7 | -22.22% |
30 Sep, 22 | 9 | 80.00% |
30 Jun, 22 | 5 | - |
31 Mar, 22 | 5 | - |
31 Dec, 21 | 5 | 25.00% |
30 Sep, 21 | 4 | - |
30 Jun, 21 | 4 | 33.33% |
31 Mar, 21 | 3 | - |
31 Dec, 20 | 3 | 50.00% |
30 Sep, 20 | 2 | 100.00% |
30 Jun, 20 | 1 | - |
31 Mar, 20 | 1 | - |
As of 30 Sep 23, 5 institutions are holding Addex Therapeutics's shares, representing an increase of 66.67% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Sep, 23 | 746,855 | 61.09% |
30 Jun, 23 | 463,613 | -92.19% |
31 Mar, 23 | 5,939,200 | 367.32% |
31 Dec, 22 | 1,270,898 | -79.24% |
30 Sep, 22 | 6,122,606 | 377.00% |
30 Jun, 22 | 1,283,553 | 20.31% |
31 Mar, 22 | 1,066,834 | -5.46% |
31 Dec, 21 | 1,128,476 | 121.73% |
30 Sep, 21 | 508,940 | 0.06% |
30 Jun, 21 | 508,655 | 81.62% |
31 Mar, 21 | 280,064 | 5.26% |
31 Dec, 20 | 266,078 | 1335.00% |
30 Sep, 20 | 18,542 | 6.45% |
30 Jun, 20 | 17,418 | - |
31 Mar, 20 | 17,418 | - |
Addex Therapeutics (ADXN) has 746.86K shares outstanding as of 30 Sep 23, up 61.09% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Sep, 23 | 6.21% | 30.10% |
30 Jun, 23 | 4.54% | 0.13% |
31 Mar, 23 | 58.18% | 20.43% |
31 Dec, 22 | 16.88% | 0.29% |
30 Sep, 22 | 76.88% | 18.20% |
30 Jun, 22 | 20.55% | 7.20% |
31 Mar, 22 | 16.89% | 4.29% |
31 Dec, 21 | 19.84% | 24.78% |
30 Sep, 21 | 8.95% | 11.15% |
30 Jun, 21 | 8.96% | 35.65% |
31 Mar, 21 | 5.01% | 22.10% |
31 Dec, 20 | 4.76% | 2740.44% |
30 Sep, 20 | 0.42% | 271.45% |
30 Jun, 20 | 0.39% | 253.97% |
31 Mar, 20 | 0.39% | - |
As of 30 Sep 23, Addex Therapeutics is held by 6.21% institutional shareholders, representing a 30.10% growth compared to 30 Jun 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Sep, 23 | 3 | 50.00% |
30 Jun, 23 | 2 | -60.00% |
31 Mar, 23 | 5 | - |
31 Dec, 22 | 5 | -28.57% |
30 Sep, 22 | 7 | 133.33% |
30 Jun, 22 | 3 | - |
31 Mar, 22 | - | -100.00% |
31 Dec, 21 | 2 | 100.00% |
30 Sep, 21 | 1 | -66.67% |
30 Jun, 21 | 3 | 50.00% |
31 Mar, 21 | 2 | - |
31 Dec, 20 | 2 | 100.00% |
30 Sep, 20 | 1 | - |
30 Jun, 20 | - | -100.00% |
31 Mar, 20 | 1 | - |
3 institutional shareholders have increased their position in ADXN stock as of 30 Sep 23 compared to 2 in the previous quarter (a 50.00% increase).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Sep, 23 | 1 | - |
30 Jun, 23 | 1 | -50.00% |
31 Mar, 23 | 2 | - |
31 Dec, 22 | 2 | 100.00% |
30 Sep, 22 | 1 | - |
30 Jun, 22 | 1 | -50.00% |
31 Mar, 22 | 2 | - |
31 Dec, 21 | - | - |
30 Sep, 21 | - | - |
30 Jun, 21 | - | - |
31 Mar, 21 | - | -100.00% |
31 Dec, 20 | 1 | - |
30 Sep, 20 | 1 | - |
30 Jun, 20 | - | - |
31 Mar, 20 | - | - |
1 institutional shareholders have reduced their position in ADXN stock as of 30 Sep 23 compared to 1 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Sep, 23 | 5 | 66.67% | 746,855 | 61.09% | 6.21% | 30.10% | 3 | 50.00% | 1 | - |
30 Jun, 23 | 3 | -57.14% | 463,613 | -92.19% | 4.54% | 0.13% | 2 | -60.00% | 1 | -50.00% |
31 Mar, 23 | 7 | - | 5,939,200 | 367.32% | 58.18% | 20.43% | 5 | - | 2 | - |
31 Dec, 22 | 7 | -22.22% | 1,270,898 | -79.24% | 16.88% | 0.29% | 5 | -28.57% | 2 | 100.00% |
30 Sep, 22 | 9 | 80.00% | 6,122,606 | 377.00% | 76.88% | 18.20% | 7 | 133.33% | 1 | - |
30 Jun, 22 | 5 | - | 1,283,553 | 20.31% | 20.55% | 7.20% | 3 | - | 1 | -50.00% |
31 Mar, 22 | 5 | - | 1,066,834 | -5.46% | 16.89% | 4.29% | - | -100.00% | 2 | - |
31 Dec, 21 | 5 | 25.00% | 1,128,476 | 121.73% | 19.84% | 24.78% | 2 | 100.00% | - | - |
30 Sep, 21 | 4 | - | 508,940 | 0.06% | 8.95% | 11.15% | 1 | -66.67% | - | - |
30 Jun, 21 | 4 | 33.33% | 508,655 | 81.62% | 8.96% | 35.65% | 3 | 50.00% | - | - |
31 Mar, 21 | 3 | - | 280,064 | 5.26% | 5.01% | 22.10% | 2 | - | - | -100.00% |
31 Dec, 20 | 3 | 50.00% | 266,078 | 1335.00% | 4.76% | 2740.44% | 2 | 100.00% | 1 | - |
30 Sep, 20 | 2 | 100.00% | 18,542 | 6.45% | 0.42% | 271.45% | 1 | - | 1 | - |
30 Jun, 20 | 1 | - | 17,418 | - | 0.39% | 253.97% | - | -100.00% | - | - |
31 Mar, 20 | 1 | - | 17,418 | - | 0.39% | - | 1 | - | - | - |
ADXN Ownership FAQ
Who Owns Addex Therapeutics?
Addex Therapeutics is owned by institutional shareholders (6.21%), insiders (0.00%), and public (93.79%). The largest institutional shareholder of Addex Therapeutics is NEA MANAGEMENT COMPANY, LLC (0% of total shares) and the top mutual fund owner is (0% of total shares).
Who are the major institutional shareholders of Addex Therapeutics?
Addex Therapeutics's major institutional shareholders are NEA MANAGEMENT COMPANY, LLC, BAADER BANK AKTIENGESELLSCHAFT, JANE STREET GROUP, LLC, ARMISTICE CAPITAL, LLC, and UBS GROUP AG. The top five shareholders own together 0% of the company's share outstanding.
How many Addex Therapeutics shareholders are there?
As of Sep 2023, there are 5 institutional shareholders of Addex Therapeutics.
What percentage of Addex Therapeutics is owned by NEA MANAGEMENT COMPANY, LLC?
NEA MANAGEMENT COMPANY, LLC owns 0 shares of Addex Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).
What percentage of Addex Therapeutics is owned by BAADER BANK AKTIENGESELLSCHAFT?
As of Dec 2023, BAADER BANK AKTIENGESELLSCHAFT holds 0 shares of Addex Therapeutics (ADXN), compromising 0% of the company, valued at $0.
What percentage of Addex Therapeutics is owned by JANE STREET GROUP, LLC?
JANE STREET GROUP, LLC is the third largest holder of Addex Therapeutics. The company owns 0 of the company's shares outstanding (worth $0).